Lupin Executive and Leadership Team

Pruthviraj Ingale, the Chief Executive Officer at Lupin, directs the overarching strategic vision for this global pharmaceutical leader. Ingale architects long-term growth initiatives while overseeing the integration of research and development with manufacturing excellence. By aligning corporate objectives with the evolving needs of the healthcare sector, the Chief Executive Officer ensures the organization maintains a competitive edge in international markets. Pruthviraj Ingale monitors the performance of diverse business units to guarantee operational efficiency and adherence to rigorous quality standards. This leadership role involves constant engagement with the Board to refine the company's trajectory in the complex pharmaceutical landscape. Through the implementation of robust governance frameworks, the Chief Executive Officer fosters a culture of innovation and accountability. Ultimately, Ingale drives the expansion of the product portfolio to address critical medical gaps, securing the company's position as a cornerstone of global health.

Arnold Lupin, the President, Chief Executive Officer Office and Chief Financial Officer at Lupin, manages the intersection of executive strategy and fiscal discipline. Arnold Lupin oversees the financial health of the organization, ensuring capital allocation supports the pursuit of a better tomorrow through pharmaceutical innovation. By directing the financial planning and analysis teams, the President, Chief Executive Officer Office and Chief Financial Officer maintains the stability required for large-scale manufacturing operations. This role involves coordinating with the executive leadership to optimize resource distribution across global markets. The President, Chief Executive Officer Office and Chief Financial Officer evaluates investment opportunities that align with the company's mission of human compassion and scientific advancement. Through meticulous oversight of balance sheets and risk management protocols, Lupin secures the financial foundation necessary for sustained growth. The executive ensures transparency in reporting while driving efficiency across all corporate financial functions.

Anil Kaushal, the Chief Executive Officer & Founding Lupinlife Consumer Healthcare Ltd Leader (100 Subsidiary of Lupin) at Lupin, spearheads the expansion into the consumer-facing healthcare market. Anil Kaushal architects the brand strategy for this subsidiary, focusing on delivering accessible wellness solutions to a broad demographic. By overseeing product development and market entry, the Chief Executive Officer & Founding Lupinlife Consumer Healthcare Ltd Leader (100 Subsidiary of Lupin) ensures that consumer needs remain at the forefront of the business model. This leadership role involves building distribution networks that reach diverse regional markets, thereby increasing the company's footprint in the retail health sector. Kaushal coordinates with the parent organization to leverage manufacturing capabilities while maintaining the agility of a consumer-focused entity. Through the execution of targeted marketing and product innovation, the Chief Executive Officer & Founding Lupinlife Consumer Healthcare Ltd Leader (100 Subsidiary of Lupin) drives revenue growth and strengthens the overall market presence of the brand.

Tommaso Nardi, the Senior Director, Corporate Strategy & To The Chief of Staff & Chief Executive Officer at Lupin, coordinates the strategic initiatives that define the company's direction. Tommaso Nardi directs the flow of information and priorities between the executive office and the broader organization. By facilitating communication and alignment, the Senior Director, Corporate Strategy & To The Chief of Staff & Chief Executive Officer ensures that the vision of the leadership team is executed across all departments. This role involves managing high-level projects that require cross-functional collaboration and strategic oversight. Nardi supports the Chief Executive Officer in navigating complex market dynamics and identifying opportunities for growth. Through the synthesis of data and strategic planning, the Senior Director, Corporate Strategy & To The Chief of Staff & Chief Executive Officer enables the organization to respond effectively to the evolving needs of the healthcare industry. The executive ensures that the company's mission remains the central focus of all strategic activities.

M. Ramesh, the Chief Financial Officer at Lupin, governs the fiscal integrity and economic strategy of the pharmaceutical manufacturing operations. M. Ramesh directs the global accounting, treasury, and tax functions to ensure compliance and operational efficiency. By analyzing market trends and cost structures, the Chief Financial Officer supports the executive team in making data-driven decisions regarding production capacity and supply chain investments. This role involves managing relationships with institutional investors and financial stakeholders to maintain market confidence. Ramesh oversees the implementation of financial controls that protect the company's assets while facilitating growth in competitive international territories. Through the optimization of working capital and the management of currency risks, the Chief Financial Officer ensures the organization remains resilient against economic volatility. The executive provides the financial insights necessary to sustain the company's commitment to human imagination and scientific progress in the pharmaceutical industry.

Sujal Thakkar, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office at Lupin, manages the strategic financial planning that underpins the company's global expansion. Sujal Thakkar directs the analysis of long-term market opportunities and capital allocation strategies. By working closely with the Global Chief Financial Officer Office, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office ensures that financial resources are directed toward high-impact pharmaceutical projects. This role involves evaluating the economic viability of new ventures and monitoring the performance of existing business segments. Thakkar provides the strategic insights required to navigate the complexities of the global healthcare market. Through the development of financial models and strategic roadmaps, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office supports the company's commitment to sustainable growth and the unwavering pursuit of a better tomorrow.

Vijay Ghogare, the Chief Operating Officer at Lupin, oversees the complex manufacturing and supply chain infrastructure that defines the company's global reach. Vijay Ghogare directs the daily operations across multiple production facilities, ensuring that pharmaceutical products meet the highest standards of quality and safety. By optimizing manufacturing processes, the Chief Operating Officer enhances productivity and reduces lead times for critical medications. This role involves coordinating with logistics and procurement teams to maintain a seamless flow of raw materials and finished goods across international borders. Ghogare implements advanced operational technologies to improve efficiency and support the company's mission of providing accessible healthcare. Through the management of large-scale industrial projects, the Chief Operating Officer ensures that the organization remains capable of meeting global demand. The executive drives continuous improvement initiatives that align operational output with the strategic goals of the company, fostering a culture of excellence in manufacturing.

Cyrus Karkaria, the President - Biotech Businesses at Lupin, directs the research, development, and commercialization of advanced biotechnological products. Cyrus Karkaria oversees the specialized teams focused on creating complex therapies that address unmet medical needs. By managing the biotech pipeline, the President - Biotech Businesses ensures that the company remains at the cutting edge of scientific innovation. This role involves navigating the regulatory and technical challenges inherent in the biotech sector to bring life-saving treatments to market. Karkaria collaborates with global research partners to leverage the latest advancements in biotechnology. Through the strategic management of the biotech portfolio, the President - Biotech Businesses drives the company's contribution to global healthcare. The executive ensures that the biotech division operates with the precision and compassion required to fulfill the company's mission. Karkaria leads the effort to translate human imagination into tangible medical solutions that improve patient lives on a global scale.

Kiritkumar Dumraliya, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) at Lupin, architects the digital transformation of the company's internal systems. Kiritkumar Dumraliya directs the implementation of advanced IT infrastructure to support pharmaceutical research and manufacturing data management. By overseeing the integration of secure digital platforms, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) ensures that information flows efficiently across global departments. This role involves managing complex technology projects that enhance operational transparency and data security. Dumraliya collaborates with the Chief Information Officer Office to align technical capabilities with the broader business objectives of the organization. Through the deployment of scalable software solutions, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) supports the company's pursuit of innovation. The executive ensures that the digital backbone of the company remains robust, enabling teams to focus on the core mission of improving patient outcomes.

Shruti Pai, the Chief Human Resources Officer at Lupin, directs the talent management and organizational development strategies that empower the workforce. Shruti Pai oversees the recruitment, training, and retention of top-tier professionals who drive the company's pharmaceutical innovations. By fostering a culture of compassion and excellence, the Chief Human Resources Officer ensures that the organization attracts individuals dedicated to the mission of global health. This role involves designing performance management systems that align individual contributions with the company's strategic goals. Pai manages the human capital requirements across diverse international regions, ensuring that the workforce remains agile and capable of meeting industry challenges. Through the implementation of inclusive workplace policies and professional development programs, the Chief Human Resources Officer supports the growth of the company's most valuable asset. The executive ensures that the organizational structure remains optimized to support the pursuit of scientific and medical breakthroughs.